Mitsubishi UFJ Asset Management Co., Ltd.
Position in LXEO — Lexeo Therapeutics, Inc.
CIK 1466546
TOKYO, M0
Position in LXEO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$146,811
-$113,444 QoQ
Shares Held
25,577
-2.4% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mitsubishi UFJ Asset Management Co., Ltd. holds $667,031,036 across 65 Biotechnology names. LXEO ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
597,497 | $266,806,310 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
240,600 | $185,897,184 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
152,197 | $50,357,421 | |
| 4 | INSM |
INSMED Inc
|
255,247 | $41,737,989 | |
| 5 | INCY |
Incyte Corp
|
366,912 | $34,533,757 | |
| 6 | MRNA |
Moderna, Inc.
|
424,625 | $21,570,950 | |
| 7 | RPRX |
Royalty Pharma plc
|
442,778 | $21,240,060 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
164,988 | $16,045,083 |
All Filings in LXEO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $146,811 | 25,577 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $260,255 | 26,209 | Shares | Defined | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||